Enhanced Anti-Cancer Potential: Investigating the Combined Effects with Coriolus versicolor Extract and Phosphatidylinositol 3-Kinase Inhibitor (LY294002) In Vitro
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26041556 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Tomasz Jędrzejewski und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Faculty of Biological and Veterinary Sciences, Nicolaus Copernicus University, Lwowska 1 Str., 87-100 Toruń, Poland. Hauptthemen laut MEDLINE: Morpholines, Chromones, Phosphoinositide-3 Kinase Inhibitors, Antineoplastic Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nicolaus Copernicus University, University of Pardubice was financed under the “Excellence Initiative—Research University”.
Abstract (Originalsprache)
Coriolus versicolor (CV), known in traditional Chinese medicine for over 2000 years, is currently used in China and Japan to reduce chemotherapy or radiotherapy side effects in cancer patients. Despite extensive research, its effects still need improvement. This study aimed to determine if combining CV extract with LY294002, an inhibitor of the phosphatidylinositol-3-kinase (PI3K) signalling pathway, enhances cancer cell treatment, potentially leading to a novel therapeutic approach. Three human cancer cell lines (MCF-7, HeLa, and A549) were treated with CV extract alone or combined with LY294002. Cell viability was assessed using MTT assays. Then, HeLa and MCF-7 cells most sensitive to the co-treatment were used to evaluate colony formation, apoptosis, cell cycle, cell migration and invasion, and phospho-PI3K expression. The results demonstrated that LY294002 enhanced the CV extract’s anti-tumour effects by reducing cell viability and colony formation. The combined treatment with CV extract and LY294002 more effectively induced G0/G1 cell cycle arrest, promoted apoptosis, reduced cell invasion and migration, and inhibited phospho-PI3K expression compared to each agent alone. This study highlights the potent cytotoxic enhancement between CV extract and LY294002 on cancer cells, primarily by inhibiting phospho-PI3K expression. These findings suggest promising avenues for developing novel combination therapies targeting cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Faculty of Biological and Veterinary Sciences, Nicolaus Copernicus University, Lwowska 1 Str., 87-100 Toruń, Poland.
- Department of Biological and Biochemical Sciences, Faculty of Chemical Technology, University of Pardubice, Studentska 573 Str., 532 10 Pardubice, Czech Republic.
ORCID-Profile: Tomasz Jędrzejewski, Justyna Sobocińska, Bartosz Maciejewski, Marcela Slovakova, Sylwia Wrotek
Förderung
- Nicolaus Copernicus University
- University of Pardubice was financed under the “Excellence Initiative—Research University”
Zitieren
APA
Jędrzejewski, T., Sobocińska, J., Maciejewski, B., Slovakova, M., & Wrotek, S. (2025). Enhanced Anti-Cancer Potential: Investigating the Combined Effects with Coriolus versicolor Extract and Phosphatidylinositol 3-Kinase Inhibitor (LY294002) In Vitro. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26041556
Vancouver
Jędrzejewski T, Sobocińska J, Maciejewski B, Slovakova M, Wrotek S. Enhanced Anti-Cancer Potential: Investigating the Combined Effects with Coriolus versicolor Extract and Phosphatidylinositol 3-Kinase Inhibitor (LY294002) In Vitro. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26041556
BibTeX
@article{Jdrzejewski2025,
author = {Jędrzejewski, Tomasz and Sobocińska, Justyna and Maciejewski, Bartosz and Slovakova, Marcela and Wrotek, Sylwia},
title = {Enhanced Anti-Cancer Potential: Investigating the Combined Effects with Coriolus versicolor Extract and Phosphatidylinositol 3-Kinase Inhibitor (LY294002) In Vitro},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26041556}
}
EUVIMED